Gina Scurti

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus”.

Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009147

N/A

0.763DataRank · unranked

13 citations

Elizabeth M. Brahmbhatt, Elena Cherkasova, Timothy T. Spear, Ujjawal Savani, Stephanie Pierre +13 more

HDAC inhibition prevents transgene expression downregulation and loss-of-function in T cell-receptor-transduced T cells

Molecular Therapy — Oncolytics(2021)10.1016/j.omto.2021.01.014

N/A

0DataRank · unranked

10 citations

Gina Scurti, Matthew DeJong, Siao‐Yi Wang, Annika V. Dalheim, Courtney Wagner +13 more

Melanoma-reactive TCR-modified T Cells Generated in the Absence of Activation Retain a Less-differentiated Phenotype and Have Increased Therapeutic Potential.

Research Square (Research Square)(2021)10.21203/rs.3.rs-238261/v1

N/A

0DataRank · unranked

0 citations

Tamson V. Moore, Annika V. Dalheim, Gina Scurti, Michael I. Nishimura, Siao‐Yi Wang

Genetic Modification of T Cells for the Immunotherapy of Cancer

Vaccines(2022)10.3390/vaccines10030457

N/A

0DataRank · unranked

9 citations

Natasha Lenart, Victoria Dronzek, Gina Scurti, Nasheed Hossain, Michael I. Nishimura +1 more

Siglec-5 is an inhibitory immune checkpoint molecule for human T cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.04.474948

N/A

0DataRank · unranked

3 citations

David G. Glanville, Gina Scurti, Paula White, Michael I. Nishimura, Andrew T. Ulijasz +2 more

Phase I results of human endogenous retrovirus type-E (HERV-E) TCR transduced T-cells in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2549

N/A

0DataRank · unranked

5 citations

Stefan Barisic, Gina Scurti, Elena Cherkasova, Long Chen, Kristen Wood +13 more

T cell receptor-engineered T cells targeting a human endogenous retrovirus in kidney cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4542

N/A

0DataRank · unranked

2 citations

Elizabeth M. Brahmbhatt, Elena Cherkasova, Rosa Nadal, Ujjawal Savani, Stephanie Pierre +12 more

H 2 S-Prdx4 axis mitigates Golgi stress to bolster tumor-reactive T cell immunotherapeutic response

Science Advances(2024)10.1126/sciadv.adp1152

N/A

0DataRank · unranked

22 citations

Paramita Chakraborty, Mohamed Faisal Kassir, James W. Dressman, Satyajit Das, Stephanie Mills +19 more

Melanoma reactive TCR-modified T cells generated without activation retain a less differentiated phenotype and mediate a superior in vivo response

Scientific Reports(2021)10.1038/s41598-021-92808-6

N/A

0DataRank · unranked

10 citations

Tamson V. Moore, Annika V. Dalheim, Gina Scurti, Michael I. Nishimura, Siao‐Yi Wang

Quantification of circulating TCR-engineered T cells targeting a human endogenous retrovirus post-adoptive transfer using nanoplate digital PCR

Molecular Therapy — Methods & Clinical Development(2024)10.1016/j.omtm.2024.101324

N/A

0DataRank · unranked

0 citations

Elena Cherkasova, Rosa Nadal, Xin Tian, Long Chen, Angelina Parrizzi +5 more